uniQure Announces Presentations at Upcoming April

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
101
uniQure Announces Presentations at Upcoming April Conferences

LEXINGTON, Mass. and AMSTERDAM, the Netherlands, April 03, 2017 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE ), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced presentations at the following conferences taking place in April:

World Orphan Drug Congress USA, April 19 – 21 2017, at the Washington Marriott Wardman Park in Washington D.C.

  • Matt Kapusta, Chief Executive Officer, will be presenting a keynote address: Adeno-associated virus (AAV)-based gene therapies for rare, chronic and degenerative diseases, on Friday April 21 st , 2017, 9.40 a.m. EDT.

12th Annual HD Therapeutics Conference by CHDI, April 24 – 27 2017, at the Westin Dragonara Resort in St. Julian’s, Malta.

  • A presentation new preclinical data on huntingtin gene silencing in a mini-pig model of Huntington’s Disease, using allele-specific and non-selective miRNAs, will be presented during the CHDI conference.

Gene Therapy for Rare Disorders Conference, April 25 – 26 2017, at the Sheraton Boston Hotel, in Boston MA.

  • Lance Weed, Vice President of US Operations, will be presenting: Optimizing the Scalability of Gene Therapy Manufacturing, on Tuesday April 25 th , 2017, 2.00 p.m. EDT.
  • Eileen Sawyer, Director of Global Medical Affairs, will be presenting: Bridging Gaps Through Early Integration of the Internal Medical Affairs Function, on Wednesday April 26 th , 2017, 11.00 a.m. EDT.
  • Daniel Leonard, Director of Global Patient Advocacy, will be presenting: The Intersection of Patient Advocacy and Gene Therapy: A Case Study in Hemophilia, on Wednesday April 26 th , 2017, 2.00 p.m. EDT.

Alliance for Regenerative Medicines (ARM)’s 5 th Annual Cell & Gene Therapy Investor Day, April 27 th 2017, at The State Room, in Boston MA.

  • Matthew Kapusta, chief executive officer, will be participating in a fireside chat on Thursday, April 27 th , 2017, 2.15 p.m. EDT.

The Company also announced its participation in the following conferences taking place in April:

Hemophilia Federation of America (HFA)’s Annual Symposium, April 6 – 9 2017, at the Rhode Island Convention Center in Providence, RI.

The International Liver Congress 2017 by EASL, April 19 – 23 2017 at the RAI in Amsterdam, The Netherlands.

About uniQure uniQure is delivering on the promise of gene therapy – single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline of proprietary and partnered gene therapies to treat patients with hemophilia, Huntington’s disease and cardiovascular diseases. www.uniQure.com

uniQure Contacts: Maria E. Cantor Direct: 339-970-7536 Mobile: 617-680-9452 m.cantor@uniQure.com Eva M. Mulder Direct: +31 20 240 6103 Mobile: +31 6 52 33 15 79 e.mulder@uniQure.com Tom Malone Direct: 339-970-7558 Mobile: 339-223-8541 t.malone@uniQure.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

DayOne's Bold Energy Moves With Sembcorp for Asia Growth

Updated Category News Views 79

It seems the digital world and power supply have locked in a new dance as DayOne Data Centers teams up with Sembcorp Utilities. It's high time we gave this story a solid look, especially with data centers gobbling energy faster than my old trading partner downs an espresso. Tackling Energy Constraints Head-On The digital infrastructure beast is hungry for power, and...

Continue Reading
Jack Henry's Q1 2027 Deconversion Revenue Hits $17.9M

Updated Category News Views 30

Jack Henry Surprises with Strong Deconversion Revenue You're probably thinking, deconversion revenue—what on earth is that? Imagine you're in the financial tech business and one of your bigwig clients decides to merge or get gobbled up by another institution. They move shop, and voila, you've got some unexpected money flowing in due to that exit. That's deconversion...

Continue Reading
Young Leaders Drive Be Strong’s Mental Health Movement

Updated Category News Views 50

New Voices at the Helm Today’s youth aren’t just tomorrow's leaders; they’re stepping up now. Groups like Be Strong’s newly minted National Student Advisory Board are proving that. Sixteen kids across eleven states are diving headfirst into transforming mental health narratives. This ain't just some school club. These young guns are gearing up to reshape how we...

Continue Reading
Spotting Alzheimer's: Holiday Visits Might Reveal More

Updated Category News Views 34

The Unspoken Truth of Holiday Reunions Is there any better barometer than a holiday visit to gauge how your parents are truly doing? Most of us are zooming in, lugging our baggage through the front door and finding Dad telling the same old story not once, not twice, but three solid times at the table. Then there’s Mom, fumbling her way through that pie recipe she could...

Continue Reading
Yale's $10M Inflammation Initiative: Future Health Impact

Updated Category News Views 45

Yale’s Inflammation Research: Beyond the Basics Inflammation. It’s the kind of battle your own body wages from within, and Yale School of Medicine’s fresh $10 million grant from the Blavatnik Family Foundation means they’re marching deeper into the trenches. This is not another academic exercise; it’s about digging out the roots of diseases that are tough to pin...

Continue Reading
CloudKeeper Simplifies AI Cost Tracking with FinOps Launch

Updated Category News Views 43

AI Cost Management: A Complex Endeavor Tracking the myriad costs of AI operations can be downright infuriating. Every company dipping its toes in these waters quickly finds itself tangled in a web of fees spanning different models, applications, and cloud services. This tangled mess is about to get some much-needed untangling, thanks to CloudKeeper's latest move. They're...

Continue Reading
Quanta Services Reports Record Q3 2026 Earnings

Updated Category News Views 79

Quanta Services Smashes Q3 2026 Expectations If you're a stakeholder in Quanta Services, you'd probably be dancing in the aisles right now. This company just posted off-the-charts numbers for the third quarter of 2026. We're talking revenues of $12 billion—a staggering leap from $7.63 billion the same quarter last year. Explosive Earnings and Strong Backlog The star of...

Continue Reading
Wabi's $1.25B Valuation: A New Era for AI?

Updated Category News Views 155

A Major Milestone for Wabi Well, here we go—Wabi, the brainchild of Eugenia Kuyda, is stirring the pot with a massive $55 million funding round, pulling its valuation up to a hefty $1.25 billion. If you're raising eyebrows at that price tag, you’re not alone. It's a big number riding on an even bigger idea: that AI isn't just for solitary chats anymore, but for...

Continue Reading
ACTEC Welcomes 55 New Fellows: A Closer Look

Updated Category News Views 99

Coffee's brewing hot, and so are the stakes at ACTEC, where 55 new Fellows just got the nod. The American College of Trust and Estate Counsel isn't your average club. They've been at this game since 1949, bringing together the finest minds in trusts and estates. But what does this newest batch bring to the table, and why should investors take a moment to notice? A Diverse...

Continue Reading
Static Media Acquires CarScoops to Boost Auto Reach

Updated Category News Views 74

Static Media's Latest Move in the Automotive Arena The digital media landscape keeps morphing, and Static Media just decided to crank up the gears a notch by snapping up CarScoops.com. For those with an eye on the automotive field, it's the kind of play that could shift the tides. Static Media, already a heavyweight with brands like Jalopnik and SlashGear under its belt,...

Continue Reading

Top 5 Most Recently Viewed Articles

AchieveIt and OpenGov Unite to Transform Public Sector Excellence

Updated Category News Views 170

AchieveIt and OpenGov Unite for Public Sector Innovation AchieveIt, a prominent player in providing strategy execution and performance management software, has announced an exciting new partnership with OpenGov, renowned for its AI and ERP solutions tailored for local and state governments in the United States. This collaboration is set to enhance public sector...

Continue Reading
Lucid Group Secures Major Funding through Stock Offering

Updated Category News Views 99

Lucid Group launched a massive public stock offering back in October 2023, pricing a whopping 262,446,931 shares of its common stock. This wasn't just about cash flow; it was part of their grand vision to carve out a chunk of the electric vehicle (EV) sector. The streets were buzzing—traders were eyeing this move closely because, let’s face it, when you throw around...

Continue Reading
Gergely Sved Takes Helm as CEO of Ellab to Drive Growth

Updated Category News Views 335

Gergely Sved Takes the Lead at Ellab Ellab, a top-notch provider of validation, monitoring, and calibration solutions, has announced the appointment of Gergely Sved as its new Chief Executive Officer (CEO), which marks a pivotal change in the company’s leadership. Following the departure of Ludvig Enlund, Sved's expertise will guide Ellab into a new era focused on...

Continue Reading
French Telecom Giants Partner with Aduna for API Innovation

Updated Category News Views 179

French Telecom Giants Embrace API Innovation with Aduna In a groundbreaking development for the telecom industry, Aduna has welcomed two of France's leading network operators, Bouygues Telecom and Free, as network partners. This partnership aims to transform the way developers interact with network APIs, significantly enhancing digital capabilities across various sectors....

Continue Reading
Dizal's Innovative Treatments in Hematology Show Promising Results

Updated Category News Views 172

Dizal's Innovations in Hematology Treatment At a recent medical meeting, Dizal, a biopharmaceutical company dedicated to developing groundbreaking therapies for cancer and immunological diseases, shared compelling new data from its hematology drug portfolio. Investors and healthcare providers alike took note of the latest findings on golidocitinib and birelentinib,...

Continue Reading